• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ile1的缺失改变了链激酶的作用机制:分子性别假说的证据。

Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis.

作者信息

Wang S, Reed G L, Hedstrom L

机构信息

Department of Biochemistry, Brandeis University, Waltham, Massachusetts 02454, USA.

出版信息

Biochemistry. 1999 Apr 20;38(16):5232-40. doi: 10.1021/bi981915h.

DOI:10.1021/bi981915h
PMID:10213631
Abstract

Plasminogen (Plgn) is usually activated by proteolytic cleavage of Arg561-Val562. The new N-terminal amino group of Val562 forms a salt bridge with Asp740, creating the active protease plasmin (Pm). However, streptokinase (SK) binds to Plgn, generating an active protease in a poorly understood, nonproteolytic process. We hypothesized that the N-terminus of SK, Ile1, substitutes for the N-terminal Val562 of Pm, forming an analogous salt bridge with Asp740. SK initially forms an inactive complex with Plgn, which subsequently rearranges to create an active complex; this rearrangement is rate limiting at 4 degrees C. SK.Plgn efficiently hydrolyzes amide substrates at 4 degrees C, although DeltaIle1-SK. Plgn has no amidolytic activity. DeltaIle1-SK prevents formation of wild-type SK.Plgn. These results indicate that DeltaIle1-SK forms the initial inactive complex with plasminogen, but cannot form the active complex. However, when the experiment is performed at 37 degrees C, amidolytic activity is observed when DeltaIle1-SK is added to plasminogen. SDS-PAGE analysis demonstrates that the amidolytic activity results from the formation of DeltaIle1-SK.Pm. To further demonstrate that the activity of DeltaIle1-SK requires the conversion of Plgn to Pm, we characterized the reaction of SK with a mutant microplasminogen, Arg561Ala-microPlgn, that cannot be converted to microplasmin. Amidolytic activity is observed when Arg561Ala-microPlgn is incubated with wild-type SK at 37 degrees C; however, no amidolytic activity is observed in the presence of DeltaIle1-SK. These observations demonstrate that the amidolytic activity of DeltaIle1-SK at 37 degrees C requires the conversion of Plgn to Pm. Our findings indicate that Ile1 of SK is required for the nonproteolytic activation of Plgn by SK and are consistent with the hypothesis that Ile1 of SK substitutes for Val562 of Pm.

摘要

纤溶酶原(Plgn)通常通过Arg561-Val562的蛋白水解切割而被激活。Val562新形成的N末端氨基与Asp740形成盐桥,从而产生活性蛋白酶纤溶酶(Pm)。然而,链激酶(SK)与Plgn结合,在一个尚未完全理解的非蛋白水解过程中产生一种活性蛋白酶。我们推测,SK的N末端Ile1替代了Pm的N末端Val562,与Asp740形成类似的盐桥。SK最初与Plgn形成无活性复合物,随后重新排列形成活性复合物;这种重排在4℃时是限速步骤。SK.Plgn在4℃时能有效水解酰胺底物,尽管缺失Ile1的SK(DeltaIle1-SK).Plgn没有酰胺水解活性。DeltaIle1-SK可阻止野生型SK.Plgn的形成。这些结果表明,DeltaIle1-SK与纤溶酶原形成初始无活性复合物,但不能形成活性复合物。然而,当在37℃进行实验时,将DeltaIle1-SK加入纤溶酶原中可观察到酰胺水解活性。SDS-PAGE分析表明,酰胺水解活性是由DeltaIle1-SK.Pm的形成所致。为进一步证明DeltaIle1-SK的活性需要Plgn转化为Pm,我们对SK与一种不能转化为微纤溶酶的突变型微纤溶酶原Arg561Ala-微Plgn的反应进行了表征。当Arg561Ala-微Plgn在37℃与野生型SK孵育时可观察到酰胺水解活性;然而,在DeltaIle1-SK存在的情况下未观察到酰胺水解活性。这些观察结果表明,DeltaIle1-SK在37℃时酰胺水解活性需要Plgn转化为Pm。我们的研究结果表明,SK的Ile1是SK对Plgn进行非蛋白水解激活所必需的,这与SK的Ile1替代Pm的Val562这一假设一致。

相似文献

1
Deletion of Ile1 changes the mechanism of streptokinase: evidence for the molecular sexuality hypothesis.Ile1的缺失改变了链激酶的作用机制:分子性别假说的证据。
Biochemistry. 1999 Apr 20;38(16):5232-40. doi: 10.1021/bi981915h.
2
Zymogen activation in the streptokinase-plasminogen complex. Ile1 is required for the formation of a functional active site.
Eur J Biochem. 2000 Jul;267(13):3994-4001. doi: 10.1046/j.1432-1327.2000.01434.x.
3
Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.链激酶C末端柔性肽在纤溶酶原激活的活性位点形成和底物识别中的功能作用。
Biochemistry. 2003 Jan 14;42(1):114-20. doi: 10.1021/bi026746m.
4
Regulation of nonproteolytic active site formation in plasminogen.纤溶酶原中非蛋白水解活性位点形成的调控。
Biochemistry. 2007 Jul 31;46(30):8879-87. doi: 10.1021/bi602591g. Epub 2007 Jul 7.
5
Epsilon amino caproic acid inhibits streptokinase-plasminogen activator complex formation and substrate binding through kringle-dependent mechanisms.ε-氨基己酸通过kringle依赖性机制抑制链激酶-纤溶酶原激活物复合物的形成和底物结合。
Biochemistry. 2000 Apr 25;39(16):4740-5. doi: 10.1021/bi992028x.
6
Functional analysis of the amino- and carboxyl-termini of streptokinase.链激酶氨基端和羧基端的功能分析。
Thromb Haemost. 1998 May;79(5):985-91.
7
Preparation of a novel streptokinase mutant with improved stability.
Thromb Haemost. 1998 May;79(5):992-7.
8
Plasminogen substrate recognition by the streptokinase-plasminogen catalytic complex is facilitated by Arg253, Lys256, and Lys257 in the streptokinase beta-domain and kringle 5 of the substrate.链激酶β结构域中的精氨酸253、赖氨酸256和赖氨酸257以及底物的kringle 5促进了链激酶-纤溶酶原催化复合物对纤溶酶原底物的识别。
J Biol Chem. 2009 Jul 17;284(29):19511-21. doi: 10.1074/jbc.M109.005512. Epub 2009 May 27.
9
[Degradation of streptokinase and the catalytic properties of the plasmin-streptokinase complex].[链激酶的降解及纤溶酶-链激酶复合物的催化特性]
Ukr Biokhim Zh (1999). 2002 May-Jun;74(3):50-7.
10
Mutation of lysines in a plasminogen binding region of streptokinase identifies residues important for generating a functional activator complex.链激酶纤溶酶原结合区域中赖氨酸的突变确定了对生成功能性激活剂复合物至关重要的残基。
Biochemistry. 1996 Dec 24;35(51):16879-85. doi: 10.1021/bi961531w.

引用本文的文献

1
Structural Biology and Protein Engineering of Thrombolytics.溶栓剂的结构生物学与蛋白质工程
Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019.
2
Dual functionality of β-tryptase protomers as both proteases and cofactors in the active tetramer.β-色氨酸酶二聚体在活性四聚体中兼具蛋白酶和辅因子双重功能。
J Biol Chem. 2018 Jun 22;293(25):9614-9628. doi: 10.1074/jbc.M117.812016. Epub 2018 Apr 16.
3
Activity Regulation by Fibrinogen and Fibrin of Streptokinase from Streptococcus Pyogenes.
化脓性链球菌纤溶酶原激活剂(链激酶)的活性受纤维蛋白原和纤维蛋白的调节
PLoS One. 2017 Jan 26;12(1):e0170936. doi: 10.1371/journal.pone.0170936. eCollection 2017.
4
PEGylation of Truncated Streptokinase Leads to Formulation of a Useful Drug with Ameliorated Attributes.截短链激酶的聚乙二醇化导致具有改善特性的有用药物的配方。
PLoS One. 2016 May 18;11(5):e0155831. doi: 10.1371/journal.pone.0155831. eCollection 2016.
5
Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity.人血栓调节蛋白表皮生长因子4、5、6结构域与链激酶的氨基末端融合赋予抗再闭塞特性以及纤溶酶介导的凝块特异性。
PLoS One. 2016 Mar 14;11(3):e0150315. doi: 10.1371/journal.pone.0150315. eCollection 2016.
6
Pathogen activators of plasminogen.纤溶酶原的病原体激活剂。
J Thromb Haemost. 2015 Jun;13 Suppl 1(0 1):S106-14. doi: 10.1111/jth.12939.
7
Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism.纤溶酶原在催化复合物中与链激酶的快速结合揭示了一种三步机制。
J Biol Chem. 2014 Oct 3;289(40):28006-18. doi: 10.1074/jbc.M114.589077. Epub 2014 Aug 19.
8
Full time course kinetics of the streptokinase-plasminogen activation pathway.链激酶-纤溶酶原激活途径的全程动力学。
J Biol Chem. 2013 Oct 11;288(41):29482-93. doi: 10.1074/jbc.M113.477935. Epub 2013 Aug 22.
9
Streptococcus uberis plasminogen activator (SUPA) activates human plasminogen through novel species-specific and fibrin-targeted mechanisms.乳房链球菌纤溶酶原激活物(SUPA)通过新型种属特异性和纤维蛋白靶向机制激活人纤溶酶原。
J Biol Chem. 2012 Jun 1;287(23):19171-6. doi: 10.1074/jbc.M112.359315. Epub 2012 Apr 19.
10
Engineering streptokinase for generation of active site-labeled plasminogen analogs.工程化链激酶用于生成活性位点标记的纤溶酶原类似物。
Anal Biochem. 2011 Aug 15;415(2):105-15. doi: 10.1016/j.ab.2011.04.025. Epub 2011 Apr 23.